Drawing for NEXTPOINT THERAPEUTICS

USPTO serial 99075290

NEXTPOINT THERAPEUTICS

Reviewed by CopyMark Law Group

Status 731Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
NGUYEN, CINDY EVANS
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 731: Status 731 means the second six-month extension to file a Statement of Use was granted. File a Statement of Use or the next extension before the deadline expires.

Need help with NEXTPOINT THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*

Plus Government fees of $450

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Chang Hong

Chang Hong Modality Law PLLC265 Franklin StreetSte 1702Boston, MA 02110

Goods and services

ClassDescriptionStatusFirst use
001Biochemicals, namely, monoclonal antibodies for in vitro scientific or research useACTIVE—
005Pharmaceutical products for the treatment of cancer; Antibodies for medical purposesACTIVE—
042Pharmaceutical products development; Pharmaceutical research and development; Research and development of medicines; Research and development in the pharmaceutical and biotechnology fields; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of immunotherapy and immuno-oncology; Research and development in the field of immunotherapy and immuno-oncologyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 11, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 11, 2026EX2GSOU EXTENSION 2 GRANTED—
Nov 11, 2026EXT2SOU EXTENSION 2 FILED—
Nov 11, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 21, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 21, 2026EX1GSOU EXTENSION 1 GRANTED—
Sep 18, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 15, 2026TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
May 15, 2026NREVNOTICE OF REVIVAL - E-MAILED—
May 15, 2026PETGPETITION TO REVIVE-GRANTED—
May 15, 2026PROATEAS PETITION TO REVIVE RECEIVED—
May 11, 2026EXT1SOU EXTENSION 1 FILED—
Nov 11, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 16, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 16, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 10, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 14, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 11, 2025DOCKASSIGNED TO EXAMINER—
Jul 29, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 10, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 10, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance